Trials / Active Not Recruiting
Active Not RecruitingNCT05178238
Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study investigators hypothesize that SARS-Cov2 infection alters the composition of the digestive microbiota and its functionality, resulting in changes in intestinal permeability and consequently in microbial digestive translocation. These changes may correlate with the magnitude of the SARS-CoV-2 viral load in the gastrointestinal tract and may have an impact on the clinical manifestations and evolvability of COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fecal sample | Fecal sample taken to investigate intestinal microbiota |
Timeline
- Start date
- 2022-01-11
- Primary completion
- 2024-01-09
- Completion
- 2026-06-01
- First posted
- 2022-01-05
- Last updated
- 2025-11-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05178238. Inclusion in this directory is not an endorsement.